On September 30, 2016, Peter W. Rodino III resigned as a member of the Board of Directors of Hemispherx Biopharma, Inc. to permit him to serve the company in a new capacity. In this regard, effective October 1, 2016, the company retained Mr. Rodino as its Executive Director for Governmental Relations, and as its General Counsel. Mr. Rodino was appointed a Director of the company in July 2013 and served in that capacity until his resignation. While on the Board, he served as Lead Director, Chairman and Financial Expert of the Audit Committee, a member of the Compensation Committee and a member of the Governance and Nomination Committee. Mr. Rodino has broad legal, financial, and executive experience. In addition to being President of Rodino Consulting LLC and managing partner at several law firms during his many years as a practicing attorney, he served as Chairman and CEO of Crossroads Health Plan, the first major Health Maintenance Organization in New Jersey.